acetylcysteine has been researched along with Apoplexy in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso, PA; Godfrey, D; Musolino, PL; Ostrem, BEL | 1 |
| Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M | 1 |
| Brown, TR; Jenkins, DD; Moss, HG; Wiest, DB | 1 |
| Baratashvili, N; Kandelaki, M; Samsonia, M | 1 |
| Alin, L; Bourassa, MW; Brand, D; Carmichael, ST; Chen, Y; Colbourne, F; Coppola, G; Darley-Usmar, V; Dietrich, K; Holman, TR; Karuppagounder, SS; Kumar, A; Milne, GL; Nadeau, CA; Perry, S; Pinto, JT; Pratico, D; Ratan, RR; Sanchez, S; Wilkinson, CM | 1 |
| Liu, KJ; Shi, H; Taheri, S; Yan, J; Zhang, Z | 1 |
| Aw, TY; Stokes, KY; Wang, B | 1 |
| Higashi, K; Igarashi, K; Toida, T | 1 |
| Beyhun, E; Cekic Gonenc, O; Demir, S; Gunduz, A; Karaca, Y; Mentese, A; Sahin, A; Turedi, S; Turkmen, S; Yulug, E | 1 |
| Fukuda, K; Higashi, K; Igarashi, K; Ishii, I; Kashiwagi, K; Mikami, T; Mizoi, M; Nakamura, T; Nishimura, K; Saiki, R; Toida, T; Tomitori, H; Yoshida, M | 1 |
| Di Napoli, M; Papa, F | 1 |
4 review(s) available for acetylcysteine and Apoplexy
| Article | Year |
|---|---|
Monogenic Causes of Cerebrovascular Disease in Childhood: A Case Series.
Topics: Acetylcysteine; Aged; Cerebrovascular Disorders; Child; Humans; Ischemic Attack, Transient; Stroke; Vascular Malformations | 2023 |
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Ceftriaxone; Dibenzazepines; Drug Repositioning; Epilepsy; Epilepsy, Post-Traumatic; Erythropoietin; Fingolimod Hydrochloride; GABA Agents; Gabapentin; Humans; Immunologic Factors; Inflammation; Interleukin 1 Receptor Antagonist Protein; Isoflurane; Levetiracetam; Losartan; Neuroprotective Agents; Oxidative Stress; Pregabalin; Pyrrolidinones; Sirolimus; Stroke; Topiramate; Translational Research, Biomedical; Vigabatrin | 2020 |
Recent Progress in Analytical Methods for Determination of Urinary 3-Hydroxypropylmercapturic Acid, a Major Metabolite of Acrolein.
Topics: Acetylcysteine; Acrolein; Animals; Biomarkers; Humans; Severity of Illness Index; Stroke | 2016 |
MLN-519. Millennium/PAION.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Cysteine Endopeptidases; Enzyme Inhibitors; Humans; Inflammation; Multienzyme Complexes; Myocardial Infarction; Neuroprotective Agents; Proteasome Endopeptidase Complex; Stroke; Ubiquitin | 2003 |
1 trial(s) available for acetylcysteine and Apoplexy
| Article | Year |
|---|---|
N-Acetylcysteine rapidly replenishes central nervous system glutathione measured via magnetic resonance spectroscopy in human neonates with hypoxic-ischemic encephalopathy.
Topics: Acetylcysteine; Adult; Female; Glutathione; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Infant, Newborn, Diseases; Magnetic Resonance Spectroscopy; Male; Oxidation-Reduction; Stroke | 2018 |
6 other study(ies) available for acetylcysteine and Apoplexy
| Article | Year |
|---|---|
[EVALUATION OF NEUROPROTECTIVE ACTIVITY OF COMPLEX IMPACT OF MAGNESIUM OF SULFATE, LAMOTRYGINE AND N-ACETYLCYSTEINE UNDER CONDITIONS OF COMBINED NORMOBARIC HYPOXIA WITH LIGATION OF RIGHT CAROTID ARTERY IN RATS].
Topics: Acetylcysteine; Administration, Oral; Animals; Animals, Outbred Strains; Brain Ischemia; Carotid Arteries; Cerebrovascular Disorders; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Injections, Intraperitoneal; Lamotrigine; Magnesium Sulfate; Male; Neuroprotective Agents; Rats; Stroke | 2018 |
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E
Topics: Acetylcysteine; Animals; Arachidonate 5-Lipoxygenase; Cation Transport Proteins; Cell Nucleus; Cells, Cultured; Cerebral Hemorrhage; Collagenases; Cytoplasm; Dinoprostone; Disease Models, Animal; Eicosanoids; Female; Free Radical Scavengers; Glutathione; Hemin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Stroke; Treatment Outcome | 2018 |
Hypoxia-inducible factor 1 contributes to N-acetylcysteine's protection in stroke.
Topics: Acetylcysteine; Animals; Brain Ischemia; Disease Models, Animal; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Rats; Reperfusion Injury; Signal Transduction; Stroke | 2014 |
The protection conferred against ischemia-reperfusion injury in the diabetic brain by N-acetylcysteine is associated with decreased dicarbonyl stress.
Topics: Acetylcysteine; Animals; Antioxidants; Blood-Brain Barrier; Brain; Cerebral Infarction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose; Glutamate-Cysteine Ligase; Glutathione; Humans; Mice; Oxidative Stress; Pyruvaldehyde; Reperfusion Injury; Stroke | 2016 |
The effect of ethyl pyruvate and N-acetylcysteine on ischemia-reperfusion injury in an experimental model of ischemic stroke.
Topics: Acetylcysteine; Animals; Brain; Brain Ischemia; Carotid Arteries; Cell Count; Female; Free Radical Scavengers; Neurons; Pyruvates; Random Allocation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Stroke | 2016 |
Inverse correlation between stroke and urinary 3-hydroxypropyl mercapturic acid, an acrolein-glutathione metabolite.
Topics: Acetylcysteine; Acrolein; Adult; Aged; Case-Control Studies; Chromatography, Liquid; Female; Glutathione; Humans; Male; Middle Aged; Stroke; Tandem Mass Spectrometry | 2012 |